A new method of urinary oligosaccharides identification by matrix-assisted laser desorption time-of-flight mass spectrometry is presented. The method involves three steps: coupling of the urinary oligosaccharides with 8-aminonaphthalene-1,3,6-trisulfonic acid; fast purification over a porous graphite carbon extraction column; and mass spectrometric analysis. Identification of urinary oligosaccharides is based on the patterns and values of the pseudomolecular ions observed. We report here the patterns in urines from patients with Pompe disease, alpha and beta mannosidoses, galacto-sialidosis, and GM1 gangliosidosis. The protocols described here allowed facile and sensitive identification of the pathognomonic oligosacchariduria present in lysosomal diseases and can be extended to any pathological oligosacchariduria.
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A new method of urinary oligosaccharides identification by matrix-assisted laser desorption time-of-flight mass spectrometry is presented. The method involves three steps: coupling of the urinary oligosaccharides with 8-aminonaphthalene-1,3,6-trisulfonic acid; fast purification over a porous graphite carbon extraction column; and mass spectrometric analysis. Identification of urinary oligosaccharides is based on the patterns and values of the pseudomolecular ions observed. We report here the patterns in urines from patients with Pompe disease, alpha and beta mannosidoses, galacto-sialidosis, and GM1 gangliosidosis. The protocols described here allowed facile and sensitive identification of the pathognomonic oligosacchariduria present in lysosomal diseases and can be extended to any pathological oligosacchariduria.
The extreme diversity of oligosaccharides that can be found in urine renders their analysis and screening extremely difficult. Oligosaccharides such as lactose, sialyllactose, or glucose tetrasaccharide (Glc 4 ), 3 or oligosaccharides bearing A, B, or O blood group determinants are commonly found in nonpathological urine samples (1, 2) . Increased oligosacchariduria is seen in the urine of lactating or pregnant women, breast milk-fed neonates, or preterm infants fed with milk fortified with Glc polymers (1, 3, 4) . Abnormal excretion of oligosaccharides is found in glycoprotein degradation disorders and in some glycogen storage diseases (5, 6) . In these lysosomal diseases, analysis of urinary oligosaccharides is used as a diagnostic aid.
Most current assays for oligosaccharides use thin-layer chromatography (7) and HPLC (7, 8) . HPLC is more sensitive and provides higher resolution than thin-layer chromatography; however, carbohydrates are revealed on thin-layer chromatography by specific staining procedures, whereas HPLC often uses nonspecific detection unless postcolumn derivatization is used (8) . Recently, fluorophore-assisted carbohydrate electrophoresis was developed for the identification of lysosomal storage diseases: oligosaccharides are labeled with a fluorescent tag, 8-aminonaphthalene-1,3,6-trisulfonic acid (ANTS), by reductive amination, and then separated by polyacrylamide gel electrophoresis (9) . The electrophoretic data are interpreted by "oligosaccharide profiling" and permit the initial screening of the lysosomal storage diseases (10) . Precise identification of urinary oligosaccharides can be achieved after purification of the oligosaccharides and compositional analysis and physico-chemical techniques such as nuclear magnetic resonance or mass spectrometry [for reviews of these methods, see Refs. (1, 6) ]. These approaches, however, are long and tedious. Another approach is the use of exoglycosidases to remove the terminal nonreducing monosaccharide; the interpretation of the modified electrophoretic or HPLC pattern gives a structural indication of the nature of the oligosaccharide; this method, therefore, is very useful. Nevertheless, in some cases the interpretation of profiles is difficult because of unsuccessful or incomplete enzymatic digestions, the diversity of the excreted structures, the purity of the exoglycosidases, and the necessary use of a large number of different enzymes (11, 12 
Molecular Diagnostics and Genetics
We here propose the use of a sensitive procedure, matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) of ANTS-derivatized oligosaccharides.
Materials and Methods materials
ANTS was obtained from Molecular Probes, Inc.; amyloglucosidase from Aspergillus niger and ␣-amylase from Bacillus amyloliquefasciens were from Boehringer Mannheim. All other chemicals were of reagent grade and were purchased from commercial sources.
urine specimens
Urine samples were obtained from patients with various lysosomal diseases, from neonates, and from healthy control persons. Urines were stored frozen until used. In cases of galacto-sialidosis and GM1 gangliosidosis, the oligosaccharides had been characterized and quantified previously (6, 13) .
derivatization of oligosaccharides with ants
Reductive amination of oligosaccharides with ANTS was performed as described by Jackson (14) . Two 100-L urine aliquots were dried in 1.5-mL microcentrifuge tubes in a centrifugal vacuum evaporator. Each dried residue was resuspended in 5 L of 0.15 mol/L ANTS in a solution of 150 mL/L acetic acid-850 mL/L water, and 5 L of sodium cyanoborohydride (0.1 mol/L) in dimethyl sulfoxide; the samples were labeled overnight (16 h) at 37°C. The reaction mixtures were dried, resuspended in 1 mL of water, and pooled. The pooled mixtures were purified by solid phase extraction (SPE) on a 1-mL column containing porous graphite carbon (PGC; 300 mg of graphite; Hypercarb ® ; Shandon Scientific), using a procedure analogous to the one described by Packer et al. (15) . Briefly, the column was washed before use with 5 mL of 500 mL/L acetonitrile-500 mL/L water containing 1 g/L trifluoroacetic acid (TFA), followed by 10 mL of water. The pooled mixtures were loaded onto the adsorbent at a flow rate of 1 mL/min; salts and excess reagents were washed off with 5 mL of water (fraction I) and 5 mL of 150 mL/L acetonitrile-850 mL/L water (fraction II); and labeled oligosaccharides were eluted with a third solvent, 250 mL/L acetonitrile-750 mL/L water containing 1 g/L TFA (fraction III). Electrophoresis of the different fractions was performed to control the elution.
electrophoresis of ants-derivatized oligosaccharides
The method used to separate ANTS-derivatized oligosaccharides used the Tris-glycine discontinuous buffer system of Laemmli (16) , except that the sodium dodecyl sulfate and the 2-mercaptoethanol were omitted from all buffers. Isocratic running gels containing 350 g/L acrylamide and 9.3 g/L N,NЈ-methylenebisacrylamide were polymerized with 25 L of an aqueous solution of 100 g/L ammonium persulfate and 10 L of N,NЈ,NЈ,NЈ-tetramethylene diamine. The electrophoretic conditions were as described by Jackson (13) . A digitized image of the gel was recorded by an imaging system based on a cooled, charge-coupled device camera and a standard ultraviolet light box.
enzyme digestions
A sample of urine (1 mL) was purified using an SPE PGC column. Fraction II, eluted with 250 mL/L acetonitrile-750 mL/L water, contained the urinary oligosaccharides and was evaporated and resuspended in 1 mL of water. To 5 L of fraction II was added 5 L of 0.1 mol/L ammonium acetate, pH 5.5, and 1.35 U of ␣-amylase from B. amyloliquefasciens.
To another 5 L of fraction II was added 5 L of 0.1 mol/L phosphate-citrate buffer, pH 5, and 0.5 mg of amyloglucosidase from A. niger. Digestions were performed for 2 h at 37°C. The reactions were stopped with 1 mL of cold ethanol, dried on a centrifugal vacuum evaporator, labeled with ANTS, and submitted to polyacrylamide gel electrophoresis. 
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Results
A typical electrophoresis of ANTS-derivatized maltooligosaccharides after purification on an SPE column is shown in Fig. 1 . The ANTS-oligosaccharides were found in fraction III, eluted with 250 mL/L acetonitrile-750 mL/L water-1.0 g/L TFA; fractions I and II, which contained salts and excess reagents, did not contain oligosaccharides.
The MALDI-TOF MS spectrum of ANTS-maltooligosaccharides recorded in the negative mode is shown in Fig. 2 
nonpathological urines
Usually, nonpathological urine does not contain a substantial amount of oligosaccharide. Nevertheless, various amounts of lactose, sialyllactose, and a glucotetrasaccharide (Glc 4 ) may sometimes be observed, with the corresponding ions at m/z 708, 999, and 1032. An example of a nonpathological urine is given in Fig. 3A .
Food supplementation with cornstarch causes the urinary excretion of Glc polymers. In Fig. 3B , a typical ANTS-oligosaccharide profile of urine from a subject on a cornstarch-supplemented diet is shown, with the presence of pseudomolecular ions [M-H] Ϫ at m/z 870, 1032, 1194, and 1518 corresponding to oligosaccharides Glc 3 , Glc 4 , Glc 5 , and Glc 7 , respectively. In the same urine, a pseudomolecular ion at m/z 999, corresponding to sialyllactose, is observed. Complete identification of the Glc polymers as limit-dextrins was done enzymatically; amyloglucosidase destroyed all of the Glc polymers, whereas ␣-amylase did not affect the profiles (data not shown). 7  7  1559  6  1  7  1567  3  2  1  6  1641  4  3  7  1680  8  8  1721  7  1  8  1729  4  2  1  7  1803  5  3  8  1842  9  9  1883  8  1  9  2004 10  10  2020  4  2  2  8  2045  9  1  10  2166 11  11  2168  6  4  10  2385  5  3  2  10 a All m/z values correspond to pseudomolecular ions resulting from the loss of one H. The nominal value of m/z is given excluding the fractional mass increment of each atom; e.g., H is counted as 1 instead of 1.008. The error in mass assignment was about Ϯ 1/1000. Incremental residue masses for the most common residues are 162 for hexose (galactose, Glc, or Man), 203 for HexNAc (N-acetylgalactosamine or GlcNAc), 291 for N-acetylneuraminic acid, and 384 for the fluorophore moiety (ANTS). Table 1 . Pompe disease. The profile of the ANTS-derivatized oligosaccharides from a patient with Pompe disease (Fig. 3C ) was characterized by a major pseudomolecular ion at m/z 1032, which corresponds to a Glc tetrasaccharide (Glc 4 ). All pseudomolecular ions of Glc polymers with a degree of polymerization up to 11 were also observed.
Clinical Chemistry
␣-Mannosidosis. The pseudomolecular ions observed in the mass spectrum of the ANTS-derivatized oligosaccharides of a patient suffering from ␣-mannosidosis (Fig. 3D) were at m/z 911, 1073, 1235, 1397, 1559, 1721, and 1883. Their interpretation gave a chemical composition of Hex n HexNAc 1 (n ϭ 2-8) for the different oligosaccharides and corresponded to Man n GlcNAc 1 . The major compound was the trisaccharide at m/z 911, corresponding to Man␣133Man␤134GlcNAc (6, 17) .
␤-Mannosidosis. The spectrum of the ANTS-oligosaccharides of a patient suffering from ␤-mannosidosis (Fig. 3E ) was characterized by a major signal at m/z 749, which could be identified as Man␤134GlcNAc (6) . No chemical compositions could be deduced from two minor ions present at m/z 1148 and 1503.
Galacto-sialidosis. The spectrum of the ANTS-derivatized oligosaccharides of a patient with galacto-sialidosis ( Table 1 . The major pseudomolecular ions and the corresponding oligosaccharide structures are given in Table 2 (6). GM1 gangliosidosis. The oligosaccharides present in the urine of the GM1 gangliosidosis patient (Fig. 3G ) had a specific mass spectrum, with major pseudomolecular ions at m/z 708, 854, 1276, 1803, and 2170, and less intense ions at 1219, 1438, and 1641. The chemical compositions deduced from these ions are listed in Table 1 . The major pseudomolecular ions and the corresponding structures in GM1 gangliosidosis are given in Table 2 .
Discussion
A rapid and simple procedure of SPE on a PGC column described by Packer et al. (15) , which allowed easy clean-up of the sample after the coupling reaction, was used to separate the coupled oligosaccharides from urinary noncarbohydrate components and from coupling reagent. We took advantage of the negative charges of the three sulfonic groups of ANTS coupled to the oligosaccharides, which increased retention to the PGC. The ANTS-derivatized neutral or sialylated oligosaccharides were eluted only by the third eluent, which contained TFA.
The purified ANTS-derivatized oligosaccharides were analyzed by a MALDI-TOF MS technique. The negatively charged sulfonic groups permitted the detection of the oligosaccharides in the negative mode. Because of the mild ionization process, each ANTS-derivatized oligosaccharide produced only one ion, corresponding to [M-H] Ϫ , and mixtures could be analyzed in one experiment. The carbohydrate composition was determined from the value of the pseudomolecular ion of each oligosaccharide ( Table  1 ). The amount of derivatized oligosaccharides loaded on the target of the MALDI-TOF mass spectrometer could be estimated from the previously determined carbohydrate chemical composition of the same urines (6, 13) . The concentration of oligosaccharides B I and B II were ϳ110 -120 mol/L and 60 mol/L, respectively, and the mass spectral pattern revealed a representative picture of the urinary oligosaccharide distribution; a similar observation was made with GM1 gangliosidosis urines (13) . In contrast to techniques that use internal standards, such as HPLC or gas chromatography-mass spectrometry, the patterns obtained with this MALDI-TOF MS technique are more qualitative than quantitative. The detection limit of the technique could be estimated in the very low picomolar range: minor oligosaccharides (A III and A IV in Table 2 ) present in the urine at concentrations of ϳ5 mol/L (13) could be identified easily. This result is in accordance with previously described detection limits (18 -20) .
Identifying the oligosaccharides present in each lysosomal storage disease on the basis of the values of the pseudomolecular ions and their intensity was easy: in Pompe disease, the presence of Glc polymers up to a degree of polymerization of 11 with a very intense peak corresponding to a Glc tetrasaccharide was characteristic and could be distinguished from urines of subjects receiving cornstarch as a food supplement. In this case, the oligosaccharides were in lower quantities and the most intense pseudomolecular ions were the Glc tri-and tetrasaccharides. The Glc penta-and hexasaccharides were present in very low concentrations, and higher-sized Glc polymers were not detected.
ANTS-derivatized oligosaccharides from ␣-mannosidosis, GM1 gangliosidosis, and galacto-sialidosis urines have very specific patterns of excreted oligosaccharides; nevertheless, the confirmation of these diseases should be made by enzymatic or genetic analysis. It should also be mentioned that other glycoprotein degradation disorders, such as aspartylglucosaminuria or Schindler disease (6, 21) , are characterized by abnormal excretion of glycopeptides and cannot be identified by this technique.
HPLC (8) or electrophoresis (10) provide only an oligosaccharide pattern, whereas the MALDI procedure described in the present work allows identification of the chemical composition of each peak observed. In the case of ambiguous pseudomolecular ions, structural identification of the compound can be achieved by sequential Clinical Chemistry 44, No. 12, 1998 digestion of the ANTS-oligosaccharides by selectively chosen exoglycosidases (11) .
This fast and sensitive technique should allow screening of numerous unclassified disorders characterized by urinary excretion of oligosaccharides, such as myoclonic encephalopathy (22) , and may also be extended to other pathologies.
